Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples